Preparando el escenario para dejar de fumar en el paciente con Trastorno Bipolarintervención breve en la práctica clínica

  1. Fernando Sarramea 1
  2. Maria José Jaen-Moreno 2
  3. Vicent Balanzá-Martínez 3
  4. Maria Isabel Osuna 4
  5. José Ángel Alcalá 1
  6. Francisco Javier Montiel 5
  7. Cristina Gómez 5
  8. María Dolores Sánchez 5
  9. Ana Belén Rico 1
  10. Justa Redondo-Écija 6
  11. Susana Gil 1
  12. Francisca Valdivia 1
  13. Javier Caballero-Villarraso 1
  14. Luis Gutiérrez-Rojas 7
  1. 1 Hospital Universitario Reina Sofía, Córdoba
  2. 2 Universidad de Córdoba
    info

    Universidad de Córdoba

    Córdoba, España

    ROR https://ror.org/05yc77b46

  3. 3 Universitat de València
    info

    Universitat de València

    Valencia, España

    ROR https://ror.org/043nxc105

  4. 4 Hospital Universitario Virgen de la Victoria, Málaga
  5. 5 Hospital Universitario de Jaén
    info

    Hospital Universitario de Jaén

    Jaén, España

    ROR https://ror.org/02ecxgj38

  6. 6 Instituto Provincial Bienestar Social, Diputación de Córdoba
  7. 7 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Erakutsi afiliazioak +
Aldizkaria:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Argitalpen urtea: 2019

Alea: 31

Zenbakia: 2

Orrialdeak: 136-146

Mota: Artikulua

DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Adicciones: Revista de socidrogalcohol

Laburpena

Tobacco consumption is the main preventable factor of mortality in smokers with bipolar disorder (BD), and any possible solutions are often blocked by prejudices over desire, and the possibilities and risks for these patients in giving up tobacco consumption. Adults with BD were recruited at 8 Mental Health Centres. Smokers were evaluated before and after a brief intervention based on the 3 A’s and classified into a ‘Stage of Change’ (SOC) and their ‘Readiness to Change’ (RTC). A multiple linear regression was used to analyze the progression in their RTC and the independent effect of different variables (pharmacological treatment, history of psychotic symptoms, current anxiety symptoms, willingness, self-perceived capacity to quit smoking and subjective perception of cognitive functioning). Of 212 stable patients diagnosed with BD, current smokers (n=101; 47.6%) were included in the intervention phase, and 80.2% completed it. At baseline, 75.2% were considering the idea of giving up smoking and, after the brief intervention, 30.9% of the patients progressed in their SOC. A significant increase in the level of RTC was observed (53.3 vs 59.3, P=0.019). Perception of cognitive performance (β=- 0.35;P=0.002), the degree of willing to quit (β=0.32;P=0.008), selfperceived capacity to quit tobacco smoking (β=-0.30;P=0.012), the patient’s age (β=-0.72;P=0.004), the age of onset of smoking (β=0.48;P=0.022) and years as a smoker (β=0.48;P=0.025) were all factors that significantly influenced the chances of improving after the short intervention. Smokers with BD consider the idea of quitting and a brief intervention developed in the every day mental health care setting improves the level of readiness. The neurocognitive dysfunction associated with BD may limit patients’ readiness to quit smoking.

Erreferentzia bibliografikoak

  • Aharonovich, E., Brooks, A. C., Nunes, E.V. & Hasin, D. S. (2008). Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug and Alcohol Dependence, 95, 279-283. doi:10.1016/j.drugalcdep.2008.01.009.
  • Al-Halabí, S., Fernández-Artamendi, S., Díaz-Mesa, E.M., García-Álvarez, L., Flórez, G., Martínez-Santamaría, E., Bobes J. (2016). Tobacco and cognitive performance in schizophrenia patients: The design of the COGNICO study. Adicciones, 29, 6-12. doi:10.20882/adicciones.724.
  • Almadana Pacheco, V., Gómez-Bastero Fernández, A.P., Valido Morales, A., Luque Crespo, E., Monserrat, S. & Montemayor Rubio, T. (2017). Anxiety, depression and tobacco abstinence. Adicciones, 29, 233-244. doi:10.20882/adicciones.761.
  • Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Evins, A.E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. Lancet, 387, 2507-2520. doi:10.1016/S0140-6736(16)30272-0.
  • Ashare, R.L., Falcone, M. & Lerman, C. (2014). Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology, 76 Pt B, 581-591. doi:10.1016/j.neuropharm.2013.04.034.
  • Balanzá-Martínez, V., Crespo-Facorro, B., González-Pinto, A. & Vieta, E. (2015). Bipolar disorder comorbid with alcohol use disorder: Focus on neurocognitive correlates. Frontiers in Physiology, 6, 108. doi:10.3389/fphys.2015.00108.
  • Baune, B.T. & Malhi, G.S. (2015). A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder. Bipolar Disorders, 17 (Suppl 2), 41-55. doi:10.1111/bdi.12341.
  • Biener, L. & Abrams, D.B. (1991). The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.
  • Borland, R., Yong, H.H., Balmford, J., Cooper, J., Cummings, K.M., O’Connor, R.J., Fong, G.T. (2010). Motivational factors predict quit attempts but not maintenance of smoking cessation: Findings from the International Tobacco Control Four country project. Nicotine and Tobacco Research, 12 Suppl, S4-11. doi:10.1093/ntr/ntq050.
  • Callaghan, R.C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Gatley, J. (2014). Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. Journal of Psychiatry Research, 48, 102-110. doi:10.1016/j.jpsychires.2013.09.014.
  • Cazard, F. & Ferreri, F. (2013). Bipolar disorders and comorbid anxiety: Prognostic impact and therapeutic challenges. Encephale 39, 66-74. doi:10.1016/j.encep.2012.04.005.
  • Ceccarini, M., Borrello, M., Pietrabissa, G., Manzoni, G.M. & Castelnuovo, G. Assessing motivation and readiness to change for weight management and control: An in-depth evaluation of three sets of instruments. Frontiers in Psychology, 6, 511. doi:10.3389/fpsyg.2015.00511.
  • Chengappa, K.N., Perkins, K.A., Brar, J.S., Schlicht, P.J., Turkin, S.R,… George, T.P. (2014). Varenicline for smoking cessation in bipolar disorder: A randomized, double-blind, placebo-controlled study. Journal Clinical of Psychiatry, 75, 765-772. doi:10.4088/JCP.13m08756.
  • Chou, K., Chen, H.K., Hung, C.H., Chen, T.T., Chen, C.M. & Wu, B.J. (2015). Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 265, 249-257. doi:10.1007/s00406-014-0515-7.
  • CIE-10., 1992. Trastornos mentales y del comportamiento, descripciones clínicas y pautas para el diagnóstico. Madrid: Meditor.
  • de Leon, J., Diaz, F.J., Aguilar, M.C., Jurado, D. & Gurpegui, M. (2006). Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophrenia Research, 86, 256-268. doi:10.1016/j.schres.2006.05.009.
  • Diaz, F.J., James, D., Botts, S., Maw, L., Susce, M.T. & de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression. Bipolar Disorders, 11, 154-165. doi:10.1111/j.1399-5618.2009.00664.x.
  • DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Velasquez M.M. & Rossi, J.S. (1991). The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59, 295–304.
  • DiClemente, C.C. & Prochascka, J.O. (1998). Toward a comprehensive, transtheoretical model of change: Stages of change and addictive behavior. In: Miller WR, Heather N, eds. Treating Addictive Behaviors. 2nd ed. New York, Plenum. Pp: 3-24.
  • DiClemente, C.C., Schlundt, D. & Gemmell, L. (2004). Readiness and stages of change in addiction treatment. American Journal on Addictions, 13, 103-119. doi:10.1080/10550490490435777.
  • DiClemente, C.C., Delahanty, J.C., Kofeldt, M.G., Dixon, L., Goldberg, R. & Lucksted, A. (2011). Stage movement following a 5A’s intervention in tobacco dependent individuals with serious mental illness (SMI). Addictive Behaviour, 36, 261-264. doi:10.1016/j.addbeh.2010.11.002.
  • Etter, M. & Etter, J.F. (2004). Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bulletin, 30, 947-956.
  • Evins, A.E., Cather, C. & Laffer, A. (2015). Treatment of tobacco use disorders in smokers with serious mental illness; toward clinical best practices. Harvard Review of Psychiatry, 23, 90-98. doi:10.1097/HRP.0000000000000063.
  • Fagerström, K.O. (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviour, 3, 235-241.
  • Fiore, M. & Panel, G. (2008). Treating tobacco use and dependence: 2008 update. Rockville MD: Department of Health and Human Services.
  • García-Portilla, M.P., Saiz, P.A., Benabarre, A., Florez, G., Bascaran, M.T., Díaz, E.M., Bobes, J. (2010). Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica, 121, 437-445. doi:10.1111/j.1600-0447.2009.01498.x.
  • García-Portilla, M.P., García-Álvarez, L., Sarramea, F., Galvan, G., Díaz-Mesa, E., Bobes-Bascaran, T., Bobes, J. (2016). It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine partches and varenicline. Schizophrenia Research, 176, 272-280. doi:10.1016/j.schres.2016.05.011.
  • George, T.P., Wu, B.S. & Weinberger, A.H. (2012). A review of smoking cessation in bipolar disorder: Implications for future research. Journal of Dual Diagnosis, 8, 126–130. doi:10.1080/15504263.2012.671717.
  • Goes, F.S. (2015). The importance of anxiety states in bipolar disorder. Current Psychiatry Reports, 17, 3. doi:10.1007/s11920-014-0540-2.
  • Gómez-Peña, M., Penelo, E., Granero, R., Fernández-Aranda, F., Alvarez-Moya, E., Santamaría, J.J., Jiménez-Murcia, S. (2011). Motivation to change and pathological gambling: Analysis of the relationship with clinical and psychopathological variables. British Journal of Clinical Psychology, 50, 196-210. doi:10.1348/014466510X511006.
  • Gonzalez-Pinto, A., Gutierrez, M., Ezcurra, J., Aizpuru, F., Mosquera, F., López, P. & de Leon, J. (1998). Tobacco smoking and bipolar disorder. Journal of Clinical Psychiatry, 59, 225-228.
  • Gutiérrez-Rojas, L., Gurpegui, M., Ayuso-Mateos, J.L., Gutiérrez-Ariza, J.A., Ruiz-Veguilla, M. & Jurado, D. (2008). Quality of life in bipolar disorder patients: A comparison with a general population sample. Bipolar Disorders, 10, 625-634. doi:10.1111/j.1399-5618.2008.00604.x.
  • Gwaltney, C.J., Metrik, J., Kahler, C.W. & Shiffman, S. (2009). Self-efficacy and smoking cessation: A meta-analysis. Psychol. Addictive Behaviour, 23, 56-66. doi:10.1037/a0013529.
  • Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
  • Heatherton, T.F., Kozlowski, L.T., Frecjer, R.C. & Fageström, K.O. (1991). The Fageström Test for Nicotine Dependence: A revision of the Fageström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
  • Heffner, J.L., Strawn, J.R., DelBello, M.P., Strakowski, S.M. & Anthenelli, R.M. (2011). The co-ocurrence of cigarette smoking and bipolar disorder: Phenomenology and treatment considerations. Bipolar Disorders, 13, 439-453. doi:10.1111/j.1399-5618.2011.00943.x.
  • Jackson, J.G., Diaz, F.J., Lopez, L., de Leon, J. (2015). A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disorders, 17, 575-597. doi:10.1111/bdi.12319.
  • Japuntich, S.J., Leventhal, A.M., Piper, M.E., Bolt, D.M., Roberts, L.J., Fiore, M.C. & Baker, T.B. (2011). Smoker characteristics and smoking-cessation milestones. American Journal of Preventive Medicine, 40, 286-294. doi:10.1016/j.amepre.2010.11.016.
  • Kruger, J., O’Halloran, A., Rosenthal, A.C., Babb, S.D. & Fiore, M.C. (2016). Receipt of evidence-based brief cessation interventions by health professionals and use of cessation assisted treatments among current adult cigarette-only smokers: National Adult Tobacco Survey, 2009-2010. BMC Public Health, 16, 141. doi:10.1186/s12889-016-2798-2.
  • Marín Romero, B., Gil Roales-Nieto, J. & Moreno San Pedro, E. (2017). Self-quitting in a Spanish sample. An exploratory study. Adicciones, 29, 210-212. doi:10.20882/adicciones.925.
  • Miller, W.R. (2011). Motivational factors in addictive behaviors. In: Miller WR and Carroll KM, (Eds). Rethinking substance abuse: What the science shows and what we should do about it. New York: Guilford Press, pp. 134-152.
  • Miskowiak, K.W., Petersen, J.Z., Ott, C.V., Knorr, U., Kessing, L.V., Gallagher, P. & Robinson, L. (2016). Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: A novel methodology. Acta Psychiatrica Scandinavica, 134, 511-521.
  • Moss, T.G., Sacco, K.A., Allen, T.M., Weinberger, A.H., Vessicchio, J.C. & George, T.P. (2009). Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence, 104, 94-99. doi:10.1111/acps.12649.
  • Prochaska, J.O. & DiClemente, C.C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395.
  • Prochaska, J.J., Reyes, R.S., Schroeder, S.A., Daniels, A.S., Doederlein, A. & Bergeson, B. (2011). An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disorders, 13, 466–473. doi:10.1111/j.1399-5618.2011.00944.x.
  • Rhodes, J.D. & Hawk, L.W. JR. (2016). Smoke and mirrors: The overnight abstinence paradigm as an index of disrupted cognitive function. Psychopharmacology, (Berl). 233, 1395-1404. doi:10.1007/s00213-016-4227-8.
  • Rice, V.H. & Stead, L.F. (2008). Nursing interventions for smoking cessation. Cochrane Database Systematic Review, CD001188. doi:10.1002/14651858.CD001188.pub3.
  • Rosa, A.R., Mercadé, C., Sánchez-Moreno, J., Solé, B., Mar Bonnin, C.D., Torrent, C., Martinez-Aran, A. (2013). Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). Journal of Affective Disorders, 150, 29-36. doi:10.1016/j.jad.2013.02.022.
  • Rüther, T., Bobes, J., De Hert, M., Svensson, T.H., Mann, K., Batra, A., Möller, H.J. (2014). EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry, 29, 65-82. doi:10.1016/j.eurpsy.2013.11.002.
  • Schroeder, S.A. (2014). Even more illness caused by smoking than previously estimated. JAMA Internal Medicine, 174, 1928-1929. doi:10.1001/jamainternmed.2014.4297.
  • Sharma, A. & Szatkowski, L. (2014). Characteristics of smokers who have never tried to quit: Evidence from the British Opinions and Lifestyle Survey. BMC Public Health, 14, 346. doi:10.1186/1471-2458-14-346.
  • Siru, R., Hulse, G.K. & Tait, R.J. (2009). Assessing motivation to quit smoking in people with mental illness: A review. Addiction, 104, 719-733. doi:10.1111/j.1360-0443.2009.02545.x.
  • Tidey, J.W. & Miller, M.E. (2015). Smoking cessation and reduction in people with chronic mental illness. BMJ, 351, h4065. doi:10.1136/bmj.h4065.
  • Torrent, C., Bonnin, C del M., Martínez-Arán, A., Valle, J., Amann, B.L., González-Pinto, A., Vieta, E. (2013). Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study. American Journal of Psychiatry, 170, 852-859. doi:10.1176/appi.ajp.2012.12070971.
  • Vieta, E., Popovic, D., Rosa, A.R., Solé, B., Grande, I., Frey, B.N., Kapczinski, F. (2013). The clinical implications of cognitive impairment and allostatic load in bipolar disorder. European Psychiatry, 28, 21-29. doi:10.1016/j.eurpsy.2011.11.007.
  • Weinberger, A.H., Krishnan-Sarin, S., Mazure, C.M. & McKee, S.A. (2008). Relationship of perceived risks of smoking cessation to symptoms of withdrawal, craving, and depression during short-term smoking abstinence. Addictive Behaviour, 33, 960-963. doi:10.1016/j.addbeh.2008.02.013.
  • West R., McNeill, A. & Raw, M. (2000). Smoking cessation guidelines for health professionals: An update. Health Education Authority. Thorax, 55, 987-999. doi:10.1016/j.eurpsy.2011.11.007.
  • West, R., Raw, M., McNeill, A., Stead, L., Aveyard, P., Bitton, J., Borland, R. (2015). Health-care interventions to promote and assist tobacco cessation: A review of efficacy, effectiveness and affordability for use in national guideline development. Addiction, 110, 1388-1403. doi:10.1111/add.12998.
  • Wu, B.S., Weinberger, A.H., Mancuso, E., Wing, V.C., Haji-Khamneh, B., Levinson, A.J. & George, T.P. (2012). A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder. Journal of Dual Diagnosis, 8, 131-132. doi:10.1080/15504263.2012.671067.
  • Young, R.C., Biggs, J.T., Ziegler, V.E. & Meyer, D.A. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.
  • Zolnierek, K.B. & Dimatteo, M.R. (2009). Physician communication and patient adherence to treatment: A meta-analysis. Medical Care, 47, 826-834. doi:10.1097/MLR.0b013e31819a5acc.
Datuen iturria: Dialnet